LcrV mutants that abolish Yersinia type III injectisome function.

Katherine Given Ligtenberg1, Nathan C Miller, Anthony Mitchell

  • 1Howard Taylor Ricketts Laboratory, Argonne National Laboratory, Argonne, IL, USA.

Journal of Bacteriology
|December 11, 2012
PubMed
Summary

Pathogenic Yersinia uses LcrV, a needle cap protein, to assemble the injectisome for effector translocation. Mutations in LcrV reveal how this protein responds to low-calcium signals to control secretion.